Literature DB >> 29582351

Comparing human peritoneal fluid and phosphate-buffered saline for drug delivery: do we need bio-relevant media?

Prabhat Bhusal1, Jamie Lee Rahiri2, Bruce Sua2, Jessica E McDonald1, Mahima Bansal1, Sara Hanning1, Manisha Sharma1, Kaushik Chandramouli1, Jeff Harrison1, Georgina Procter3, Gavin Andrews3, David S Jones3, Andrew G Hill2, Darren Svirskis4.   

Abstract

An understanding of biological fluids at the site of administration is important to predict the fate of drug delivery systems in vivo. Little is known about peritoneal fluid; therefore, we have investigated this biological fluid and compared it to phosphate-buffered saline, a synthetic media commonly used for in vitro evaluation of intraperitoneal drug delivery systems. Human peritoneal fluid samples were analysed for electrolyte, protein and lipid levels. In addition, physicochemical properties were measured alongside rheological parameters. Significant inter-patient variations were observed with regard to pH (p < 0.001), buffer capacity (p < 0.05), osmolality (p < 0.001) and surface tension (p < 0.05). All the investigated physicochemical properties of peritoneal fluid differed from phosphate-buffered saline (p < 0.001). Rheological examination of peritoneal fluid demonstrated non-Newtonian shear thinning behaviour and predominantly exhibited the characteristics of an entangled network. Inter-patient and inter-day variability in the viscosity of peritoneal fluid was observed. The solubility of the local anaesthetic lidocaine in peritoneal fluid was significantly higher (p < 0.05) when compared to phosphate-buffered saline. Interestingly, the dissolution rate of lidocaine was not significantly different between the synthetic and biological media. Importantly, and with relevance to intraperitoneal drug delivery systems, the sustained release of lidocaine from a thermosensitive gel formulation occurred at a significantly faster rate into peritoneal fluid. Collectively, these data demonstrate the variation between commonly used synthetic media and human peritoneal fluid. The differences in drug release rates observed illustrate the need for bio-relevant media, which ultimately would improve in vitro-in vivo correlation.

Entities:  

Keywords:  Biological fluid; Composition; Dissolution; In vivo-in vitro correlation; Intraperitoneal; Rheology; Solubility; Surgical

Mesh:

Substances:

Year:  2018        PMID: 29582351     DOI: 10.1007/s13346-018-0513-9

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   4.617


  30 in total

Review 1.  Controlled release drug delivery systems to improve post-operative pharmacotherapy.

Authors:  Prabhat Bhusal; Jeff Harrison; Manisha Sharma; David S Jones; Andrew G Hill; Darren Svirskis
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

2.  Effect of surface active agents on drug release from polylactic acid-hydrocortisone microcapsules.

Authors:  N Leelarasamee; S A Howard; J K Ma
Journal:  J Microencapsul       Date:  1988 Jan-Mar       Impact factor: 3.142

3.  Influence of micro-environmental pH on the gel layer behavior and release of a basic drug from various hydrophilic matrices.

Authors:  Manthena V S Varma; Aditya M Kaushal; Sanjay Garg
Journal:  J Control Release       Date:  2005-01-25       Impact factor: 9.776

4.  A novel drug delivery system of intraperitoneal chemotherapy for peritoneal carcinomatosis using gelatin microspheres incorporating cisplatin.

Authors:  Shutaro Gunji; Kazukata Obama; Makoto Matsui; Yasuhiko Tabata; Yoshiharu Sakai
Journal:  Surgery       Date:  2013-09-03       Impact factor: 3.982

Review 5.  Composition and physicochemical properties of fasted-state human duodenal and jejunal fluid: a critical evaluation of the available data.

Authors:  Alexander Fuchs; Jennifer B Dressman
Journal:  J Pharm Sci       Date:  2014-10-02       Impact factor: 3.534

6.  In vivo anti-tumor effect through the controlled release of cisplatin from biodegradable gelatin hydrogel.

Authors:  Mitsunaga Konishi; Yasuhiko Tabata; Masatoshi Kariya; Ayako Suzuki; Masaki Mandai; Kanako Nanbu; Kenji Takakura; Shingo Fujii
Journal:  J Control Release       Date:  2003-10-30       Impact factor: 9.776

7.  Lecithin-based emulsions for potential use as saliva substitutes in patients with xerostomia--viscoelastic properties.

Authors:  Sara M Hanning; Tao Yu; David S Jones; Gavin P Andrews; Jules A Kieser; Natalie J Medlicott
Journal:  Int J Pharm       Date:  2013-08-18       Impact factor: 5.875

8.  Regulation of intracellular pH by human peripheral blood lymphocytes as measured by 19F NMR.

Authors:  C Deutsch; J S Taylor; D F Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

9.  Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory.

Authors:  N Faisant; J Akiki; F Siepmann; J P Benoit; J Siepmann
Journal:  Int J Pharm       Date:  2006-02-28       Impact factor: 5.875

10.  Injectable thermosensitive gelling delivery system for the sustained release of lidocaine.

Authors:  Darren Svirskis; Kaushik Chandramouli; Prabhat Bhusal; Zimei Wu; Jolyene Alphonso; Joyce Chow; Divya Patel; Riddhi Ramakrishna; Seung J Yeo; Renus Stowers; Andrew Hill; Jacob Munro; Simon W Young; Manisha Sharma
Journal:  Ther Deliv       Date:  2016-06-02
View more
  3 in total

1.  Toward understanding polymer micelle stability: Density ultracentrifugation offers insight into polymer micelle stability in human fluids.

Authors:  Timothy D Langridge; Richard A Gemeinhart
Journal:  J Control Release       Date:  2019-12-24       Impact factor: 9.776

2.  iTRAQ‑based proteomics analysis of the therapeutic effects of combined anticancer bioactive peptides and oxaliplatin on gastric cancer cells.

Authors:  Yanan Xu; Xian Li; Xiulan Su
Journal:  Oncol Rep       Date:  2019-11-11       Impact factor: 3.906

3.  Muscle Tissue as a Surrogate for In Vitro Drug Release Testing of Parenteral Depot Microspheres.

Authors:  Jan Kozak; Miloslava Rabiskova; Alf Lamprecht
Journal:  AAPS PharmSciTech       Date:  2021-03-29       Impact factor: 3.246

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.